Nicholas Delillo

Background

About Nicholas Delillo

Nick DeLillo is a Medical Director at Evolution Medical Communications, specializing in the planning and development of creative, scientifically-accurate, and innovative healthcare communication strategies intended for diverse audiences across multiple communications platforms. His role involves the development of medical strategies and content throughout all aspects of drug development from molecule to maturity including strategic positioning, scientific messaging, product launches, branding, clinical trial data dieesmination, conferences, symposia, key opinion leader development, and advisory board meetings. Nick graduated with a BA in English Literature from Manhattan College and a PhD in Molecular Biology from St. John's University. His thesis centered on chromatin remodeling and kinetochore function in S. cerevisiae cells harboring phospholipase C mutations. With 14+ years of experience in healthcare communications, Nick has worked in a diverse range of treatment settings, including but not limited to oncology, ophthalmology, infectious disease, central nervous system disorders, and respiratory disorders. His current and previous clients include some of the largest pharmaceutical and medical device companies in the US and globally. Nick takes great enjoyment in mentoring those individuals leaving the lab and seeking career direction. As someone who has "bootstrapped" himself to his current role, he shows his gratitude to his mentors by offering the same guidance and support to anyone who is unsure of their career path.